Press & Media
News Center
Stay updated with the latest press releases and news from RudaCure.
RudaCure Magazine
Our quarterly magazine covering the latest research progress and company updates. Available for free PDF download.
LatestDownload PDF
Vol.15
2026.1Q
Download PDF
Vol.14
2025.4Q
Download PDF
Vol.13
2025.3Q
Download PDF
Vol.12
2025.2Q
Download PDF
Vol.11
2025.1Q
Download PDF
Vol.10
2024.4Q
Download PDF
Vol.9
2024.3Q
Download PDF
Vol.8
2024.2Q
Download PDF
Vol.7
2024.1Q
Download PDF
Vol.6
2023.4Q
Download PDF
Vol.5
2023.3Q
Download PDF
Vol.4
2023.2Q
Download PDF
Vol.3
2023.1Q
Download PDF
Vol.2
2022.4Q
Download PDF
Vol.1
2021.3Q~2022.3Q
Company2025-10-15
2025 Pain Therapeutics Summit 참석
Company2025-08-11
[Interview] RudaCure focuses on root causes of pain — developing side-effect-free chronic pain and dry eye treatments
Company2025-07-21
RudaCure holds 7th anniversary celebration ceremony
Company2025-07-12
2025 H1 performance review and H2 goal-setting workshop successfully completed
Company2025-06-12
RudaCure pursues global partnering for RCI001/RCI002 and gene therapy co-development at 2025 BIO-USA
Company2025-05-12
RudaCure conducts plogging and blood donation campaign in Gwangmyeong on Culture Day
Company2025-05-09
2025 Bio-Korea 참석
Company2025-04-30
Culture Day event: Anyang Stream plogging and Gwangmyeong blood donation
Company2025-04-10
Attendance at DEALMAKER ACADEMY global bio-partnering seminar
Company2025-03-27
Attendance at 2025 Bio-Europe Spring and Ceva visit in France
Company2025-02-13
POSTECH Prof. Dohun Kwon seminar on TRPV1 structural analysis
Company2024-12-16
RudaCure develops dry eye treatment with reduced drug exposure period [Core Innovation Korea 2024]
Company2024-10-23
Efficacy of RCI001 as a Therapeutic Candidate in a Primary Sjögren Syndrome Mouse Model
Company2024-06-07
RudaCure Inc. attends global bio expo BIO USA 2024
Company2024-06-01
Efficacy of RCI001 as a therapeutic candidate of dry eye disease in a modified mixed dry eye model
Company2024-05-20
Global biopharmaceutical company RudaCure puts ESG management into full practice in line with the latest management trends
Company2024-05-09
Incheon Free Economic Zone Agency operates IFEZ bio-health supply chain special pavilion at BIO KOREA 2024
Company2024-04-03
IBK Innovation Hub Europe accelerator program — 8 promising startups head to Europe
Company2024-03-15
6th Annual General Shareholders' Meeting
Company2024-03-14
Visit to France's Ceva for RCI001AH joint research
Company2024-01-08
2024 RudaCure New Year Ceremony
Company2023-11-14
Korea Health Industry Development Institute supports 38 companies at Bio Europe 2023
Company2023-11-14
[Cover Story] Key targets and development hurdles for non-narcotic analgesics
Company2023-11-02
KICDC/Defy Pitch Competition Final Round Prize
Company2023-10-18
Prof. Kim Dong-hyun at Anam Hospital demonstrates long-term safety of RCI001
Company2023-10-11
Global Innovation Roadshow in Singapore
Company2023-10-09
Comparison of RCI001 and corticosteroid on the effects on intraocular pressure in mice
Company2023-10-06
Attendance at The University of Utah Asia Campus event
Company2023-07-14
Comparison of Corneal Epithelial Wound Healing between Topical RCI001, Solcoseryl, and Polydeoxyribo
Company2023-05-04
IP listing specialist Darae Strategic Commercialization Center joins forces with pain drug developer RudaCure Inc.
Company2023-03-28
Bio-venture RudaCure joins hands with veterinary drug leaders Onhil and Onhil Pet for animal drug development
Company2023-03-21
2023 Bio-EU Partnering Meeting in progress
Company2023-03-14
5th Annual General Shareholders' Meeting convened
Company2023-02-10
Technology-armed K-BIO ventures hit consecutive jackpots
Company2023-01-20
Songdo Bio Complex — a matured commercialization-focused bio cluster
Company2023-01-16
Incheon Free Economic Zone supports startup product/service early commercialization
Company2022-12-01
CDISC adoption in pharma-bio industry: a necessity, not an option
Company2022-11-29
[2022 BigWave Startup CEO] RudaCure — a startup developing eye disease and chronic pain treatments
Company2022-11-28
[Bio-health startup support platform fostering unicorn companies worth KRW 1T]
Company2022-10-28
Journal of Ocular Pharmacology and TherapeuticsOcular Distribution and Pharmacokinetics of8-Oxo-2′-Deoxyguanosine:A Novel Therapeutic Candidate of Ocular Surface Diseases
Company2022-09-30
Innovator’s Pitch Challenge Winners at RESI Boston[LIFE SCIENCE NATION NEXT PHASE NEWSLETTER]
Company2022-09-29
Non-narcotic analgesics take center stage — domestic development race heats up
Company2022-09-26
RESI Innovator's Pitch Challenge — 3rd place
Company2022-09-16
2022 Shareholders' Meeting
Company2022-09-15
Attending 2022 RESI Conference
Company2022-08-14
UKC2022 참석
Company2022-08-14
Seoul office relocation completed
Company2022-08-08
The Bell: Unlisted pharma-bio funding review — small molecule + inhibitor funding tops
Company2022-06-28
RudaCure plans H2 domestic Phase 1 for Rac1 inhibitor dry eye treatment
Company2022-06-16
RudaCure: overcoming steroid limitations with dry eye drug RCI001
Company2022-06-08
First in-person BIO-USA in 3 years — K-Bio unveils post-COVID strategy
Company2022-06-08
Korea Bio Association operates Korean pavilion at 2022 BIO-USA
Company2022-06-07
Innovative dry eye drug compound RCI001 draws renewed attention
Company2022-05-30
IFEZ introduction video: RudaCure — dry eye treatment developer
Company2022-05-20
Woongbi launches FLIPR-based service with Molecular Devices
Company2022-04-19
Breaking into the global pharmaceutical market
Company2022-03-24
Investigating the Anti-Inflammatory Effects of RCI001 for Treating Ocular Surface Diseases: Insight
Company2022-03-11
ARVO 2022 Poster Presentation
Company2022-02-21
[Doctor Startup] Embracing even the pain — a story of passion
Company2022-02-16
Bio startups take on US market challenge — launched at KIC Washington
Company2022-02-16
Comparison of therapeutic effects between topical 8-oxo-2'-deoxyguanosine and corticosteroid in ocul
Company2022-02-11
Biospectator: RudaCure discovers TRPV1-targeting analgesic — avoiding hyperthermia
Company2022-02-10
2022 JPM conference meetings successfully concluded
Company2021-12-30
K-Bio ventures pursue global drug development — notable companies and differentiators in 2021
Company2021-12-30
Pharmaceutical companies line up to develop dry eye treatments
Company2021-12-06
MOTIE R&D Rediscovery project completed
Company2021-10-14
BMC: Improved accuracy of intraocular lens power calculation by preoperative management of dry eye d
Company2021-10-10
Startup Spotlight: Getting to know RudaCure!
Company2021-09-06
Prime Minister Kim Bu-gyeom visits Korea's first Incheon Startup Park
Company2021-08-19
RudaCure U.S.A. Inc 설립
Company2021-08-05
TRPV1-targeting pharmaceutical composition European patent application completed
Company2021-07-16
Who will be the future unicorn? Incheon Startup Park builds the path
Company2021-07-03
Minister Moon pledges support for Songdo bio-cluster — attends bio-company roundtable
Company2021-06-11
BioKorea2021 참석
Company2021-05-29
Patent No. 10-2019-0083683: Method for enhancing stem cell migration to cancer cells
Company2021-05-24
From dry eye to pain — developing treatments for quality-of-life sensory disorders
Company2021-05-18
[Incheon Startup Park Rising Stars] (9) RudaCure
Company2021-04-21
Short-Term Therapeutic Effects of Topical Corticosteroids on Refractory Dry Eye Disease: Clinical Us
Company2021-04-20
Green light for domestic dry eye innovation drug — RCI001 more effective than steroids with fewer side effects (Nature Scientific Reports)
Company2021-04-16
2021 ARVO Presentation(Open May 1st)
Company2021-03-17
Headquarters address changed following relocation to Incheon Startup Park
Company2020-12-24
PCT application filed for TRPV1-targeting pharmaceutical composition
Company2020-12-12
Drug success rate 1 in 10,000 — bio-venture challenge continues (Herald Economy)
Company2020-07-31
Now a must-ask when joining SMEs: do they offer government vacation subsidies?
Company2020-07-27
[Special Feature] IFEZ growth strategy — from bio-cluster to Songdo's new bio nest
Company2020-06-10
Hankook Kyungjae: RudaCure's challenge — pain relief through protein genes (20x more effective, no tolerance/addiction)
Company2020-04-22
Metimedi, RudaCure, Voronoi go all-in on COVID-19 and new drug R&D
Company2020-02-07
8-oxo-deoxyguanosine pharmaceutical composition for corneal damage treatment
Company2020-02-07
Opening a new era in pain and eye disease drug research
Company2019-12-13
Bundang CHA Hospital and RudaCure co-develop spine regeneration therapy
Company2019-12-13
RudaCure EVP Han In-bo receives Minister of Health and Welfare commendation
Company2019-12-13